BIOREGENX, INC. Quarterly Operating Margin in % from Q4 2022 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Bioregenx, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q4 2024.
  • Bioregenx, Inc. Operating Margin for the quarter ending December 31, 2024 was -973 %, a 873% decline year-over-year.
  • Bioregenx, Inc. annual Operating Margin for 2024 was -973 %, a 873% decline from 2023.
  • Bioregenx, Inc. annual Operating Margin for 2023 was -99.9 %, a 46.2% increase from 2022.
  • Bioregenx, Inc. annual Operating Margin for 2022 was -186 %, a 123% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -973 -873 -873% Oct 1, 2024 Dec 31, 2024
Q3 2024 -182 -65.3 -55.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -247 -209 -556% Apr 1, 2024 Jun 30, 2024
Q1 2024 -218 -198 -977% Jan 1, 2024 Mar 31, 2024
Q4 2023 -99.9 +85.8 +46.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -117 Jul 1, 2023 Sep 30, 2023
Q2 2023 -37.6 Apr 1, 2023 Jun 30, 2023
Q1 2023 -20.3 Jan 1, 2023 Mar 31, 2023
Q4 2022 -186 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.